Speaker illustration

Doctor Lourdes Vicent Alaminos

University Hospital 12 de Octubre, Madrid (Spain)

Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Cardiometabolic

Thumbnail

Seasonality in mortality in a cardiology department: a five-year analysis

Event: Acute Cardiovascular Care 2019

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Acute Cardiac Care

Thumbnail

Clinical profile of a cohort of patients presenting sustained ventricular arrhythmias shortly after sacubitril/valsartan initiation.

Event: Acute Cardiovascular Care 2019

Topic: Clinical

Session: Arrhythmias, Syncope and Bradycardia and Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Thumbnail

Statin use in octogenarians after a non-ST segment elevation acute coronary syndrome.

Event: Acute Cardiovascular Care 2019

Topic: Lipid-Lowering Agents

Session: Moderated Poster 2: Pulmonary, general ICU and organization of care

Thumbnail

An overview of end-of-life issues in a cardiology department. Is the mode of death worse in the cardiac intensive care unit?

Event: Acute Cardiovascular Care 2019

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session: Moderated Poster 2: Pulmonary, general ICU and organization of care

Thumbnail

Elderly females with acute coronary syndrome present frailty and readmissions more frequently than males

Event: ESC Congress 2018

Topic: Cardiovascular Disease in the Elderly

Session: The ageing heart: a target for interventions and aggressive pharmacotherapy

Thumbnail

Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

The clinical profile of a non-selected population treated with sacubitril/valsartan is different from PARADIGM-HF trial

Event: Heart Failure 2018

Topic: Treatment

Session: Heart failure prognosis and the options to improve

Thumbnail

Sailing in troubled waters: the key role of ECMO circulatory support in arrhythmic storm

Event: Acute Cardiovascular Care 2018

Topic: Ventricular Arrhythmias and SCD - Treatment

Session: Case reports

Thumbnail

Arrhythmic storm after initiating sacubitril/valsartan

Event: Acute Cardiovascular Care 2018

Topic: Ventricular Arrhythmias and SCD - Clinical

Session: Arrhythmias & Sudden Cardiac Death

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb